The ophthalmic lens maker posted a 65% sequential profit jump, turning a loss from the same quarter last year into a profit.
GKB Ophthalmics reported a profit of ₹1.85 crore in Q1 FY27, a sharp sequential improvement and a significant recovery from a loss a year ago, even as revenue growth remained modest.
GKB Ophthalmics has started its fiscal year with a clear profit recovery, turning last year's loss into a gain on the back of improved operational performance. While revenue growth was modest, the company's focus on profitability delivered a much stronger bottom line compared to both the previous quarter and the same period last year.
The latest quarter saw revenue of ₹33.04 crore, a 2.3% increase year-on-year and a healthy 10.9% rise from the previous quarter. The real story, however, is in profit, which swung to ₹1.85 crore from a loss of ₹0.64 crore in Q1 FY26. This represents a 65.2% jump from the ₹1.12 crore profit in Q4 FY26. Consequently, the net profit margin expanded significantly to 5.6%, a marked improvement from -2.0% a year ago and 3.8% last quarter.
A look at the last five quarters shows a volatile but improving profit trajectory, with the company now posting its second-highest quarterly profit in this period.
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin (%)
| Metric | CurrentQ1 FY27 | PreviousQ4 FY26 | Same quarter LYQ1 FY26 |
|---|---|---|---|
| Revenue (₹ Cr) | 33.04YoY +2.3% | 29.79 | 32.30 |
| Profit (₹ Cr) | 1.85YoY +389% | 1.12 | -0.64 |
| Net Profit Margin (%) | 5.6YoY +380% | 3.8 | -2.0 |
Key Points
The challenge for GKB will be to sustain this improved margin profile while reigniting stronger top-line growth in the quarters ahead.
Live Chart
· GKB
(BSE)
ISIN: INE265D01015
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.